title: Reply: Beta-blockers for angina: time to reassess the specific impact of drug therapy in coronary heart disease patients.
authors.forename: Mark A
authors.initials: MA
authors.lastname: Hlatky
authors.forename: Charlotte
authors.initials: C
authors.lastname: Andersson
authors.forename: Tara I
authors.initials: TI
authors.lastname: Chang
authors.forename: Dhruv
authors.initials: D
authors.lastname: Kazi
authors.forename: Matthew D
authors.initials: MD
authors.lastname: Solomon
authors.forename: Alan S
authors.initials: AS
authors.lastname: Go
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000494:pharmacology* / Q000627:therapeutic use*; D003327:Coronary Disease / Q000175:diagnosis* / Q000188:drug therapy*; D005260:Female; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D008297:Male
chemical_list: D000319:Adrenergic beta-Antagonists